TuesdayApr 04, 2023 11:15 am

Green Housing Market Coast-to-Coast Creates Opportunity for GeoSolar Technologies Inc.

Assurance released a new study ranking every state for 11 sustainability factors ranging from solar power to electric heat and recycling regulations, with Oregon coming out on top GeoSolar Technologies is an emerging leader in the space with its new Smart Green(TM) Home that includes a rooftop solar system, geothermal loops, EV charging station, and more As measured by the HERS Index, a Smart Green(TM) Home is essentially 100% more efficient than a typical home built in 2006 Whether motivated by financial incentives, environmental concerns, or both, people are increasingly looking to climate and wallet friendly technologies in their homes.…

Continue Reading

TuesdayApr 04, 2023 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Announces 2022 Financial Results With 65% YoY Growth in Revenues

Cepton, Inc. recently published its 4Q22 and FY22 financial results The company revealed that it had generated FY22 revenues of $7.4 million, up by 65% relative to FY21 results. Furthermore, Cepton guided for FY23 revenues of $15-20 million Cepton is at the forefront of lidar technology development, a position they’ve further consolidated with the recent launch of their award-winning Vista® X-120 Plus sensors Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance MMT® lidar solutions, recently announced their financial results for the fourth quarter and full year ending December 31, 2022 (https://ibn.fm/6wp95). The company reported full year 2022…

Continue Reading

TuesdayApr 04, 2023 9:45 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Is ‘One to Watch’

The FEXD management team has extensive international experience in developing global fintech platforms and services The company in September 2022 announced a business combination with Rana Financial, which provides transfer of funds services between the U.S. and Latin America At that same time, FEXD announced the acquisition of Afinoz, a digital lending platform used by India’s leading banks In January 2023 the company announced an extension to close its announced business combinations with Rana and Afinoz through April 2023 Fintech Ecosystem Development (NASDAQ: FEXD) is a special purpose acquisition company (“SPAC”) formed for the purpose of effecting one or more…

Continue Reading

TuesdayApr 04, 2023 9:00 am

SideChannel Inc. (SDCH) Helping Improve Businesses’ Cybersecurity Attack Readiness Through Affordable and Robust Cybersecurity Support

It is estimated that as a result of the COVID-19 pandemic, cybercrime, including theft, data hacking, and destruction, grew by 600%, forcing nearly every industry to embrace new cybersecurity solutions Cybercrime is projected to cost companies worldwide an estimated $10.5 trillion annually by 2025, up from $3 trillion in 2015. However, the hefty upfront cost associated with protecting businesses from these attacks is leaving most SMBs vulnerable SideChannel acknowledges this issue, and through its team of vCISOs and vCPOs, it is lowering the barrier of entry to access fundamental cybersecurity services, ultimately providing a robust yet affordable solution By doing…

Continue Reading

MondayApr 03, 2023 3:16 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Foundation for Improving Effectiveness of Lipophilic Drugs, APIs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is positioned for opportunity with its patented DehydraTECH(TM) technology and its wide-reaching potential. “Lexaria’s DehydraTECH is designed to formulate and deliver lipophilic (fat-soluble) drugs and active pharmaceutical ingredients (‘APIs’). DehydraTECH increases the effectiveness of and improves the way APIs enter the bloodstream. The benefits of consuming a DehydraTECH-enabled drug or product include: speed up in delivery time; increased bioavailability; increased brain absorption; improved drug potency; and reduction in drug administration costs. Animal studies of DehydraTECH have demonstrated the ability to elevate the quantity of the drug delivered across…

Continue Reading

MondayApr 03, 2023 2:55 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Holds Significant Advantages to Existing Therapies

BiondVax (NASDAQ: BVXV), which focuses on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has shown, through an ongoing in vivo preclinical proof-of-concept study, that its lead NanoAb candidate for the treatment of COVID-19 exhibits clear competitive advantages over existing monoclonal antibodies (“mAbs”) and oral therapies. “According to statistically significant results released early January, BiondVax established that its inhaled therapy virtually eliminated the SARS-CoV-2 virus and prevented illness when administered prophylactically… The second set of results, announced January 23, evidenced that when the NanoAb was administered by inhalation three hours before infection,…

Continue Reading

MondayApr 03, 2023 2:32 pm

QualityStocksNewsBreaks – McEwen Mining Inc.’s (NYSE: MUX) (TSX: MUX) Subsidiary Collaborating in Vision to ‘Build a Mine for the Future’

McEwen Mining’s (NYSE: MUX) (TSX: MUX) 51.9%-owned subsidiary, McEwen Copper, recently closed an ARS 30 billion investment by FCA Argentina S.A., a subsidiary of Stellantis N.V. (NYSE: STLA). Proceeds from the investment are expected to be directed toward advancing the development of McEwen Copper’s 100%-owned Los Azules project in San Juan, Argentina. “We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” McEwen Copper CEO Rob McEwen is quoted as saying of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that…

Continue Reading

MondayApr 03, 2023 2:19 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces New PO from California College, New Service Deal with Denver Airport

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an order from Mt. San Antonio College. The order is for 11 K1 Blue Light Towers and 7 K1 Emergency Phones along with a one-year full-service maintenance plan. In addition, the company inked a deal with the Denver International Airport Annual to provide a monitoring and wireless service plan for 40 K1 Call Boxes that are installed along the main road leading to and from the airport as well as at other locations around the airport property. Located in California, Mt. San…

Continue Reading

MondayApr 03, 2023 12:58 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Q4 and FY 2022 Financial Results

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced results for the fourth quarter and year ended Dec. 31, 2022. Among the highlights, the company reported $6,196,743 in revenues compared to $2,876,273 for the year ended Dec. 31, 2021. “I am extremely pleased with how far we have come in such a short time,” said Brian John, CEO of Jupiter Wellness. “In 2022, we shifted out of the CBD space and acquired and established new unique IP and products with little competition. We look forward to focusing on selling our brands and becoming profitable…

Continue Reading

MondayApr 03, 2023 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the full year ended Dec. 31, 2022. The company also provided a clinical update of its anti-cancer drug candidate currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of 2022, we made significant advancements in our ongoing clinical trial for Berubicin. We have expanded our clinical trial sites across Europe and continued with an encouraging and increasingly rapid pace of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered